![](/img/cover-not-exists.png)
[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - THU0691 Is serum amyloid a protein an useful biomarker to monitor treatment with anti-tumour necrosis factor-alpha agents in spondyloarthritis patients?
Aguiar, F, Rosa-Gonçalves, D, Martins-Rocha, T, Ferreira, RM, Bernardo, A, Brito, I, Bernardes, MLanguage:
english
DOI:
10.1136/annrheumdis-2017-eular.5492
File:
PDF, 355 KB
english